OMCL

MKT CAP:$2B

Omnicell, Inc.

Market Cap

$2B

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$37.80-$7.34 (-16.26%)

Apr 20, 2026

Company Details

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions ...

CEO

Randall A. Lipps

IPO Date

Aug 9, 2001

Website

www.omnicell.com

Key Metrics TTM

Revenue

$1.2B

+6.5% YoY

Net Income

$2M

EPS (Diluted)

$0.04

Free Cash Flow

$84M

Revenue / Share

$26.35

Gross Margin

42.5%

Operating Margin

0.4%

Net Margin

0.2%

FCF Margin

7.1%

P/S

1.4x

P/E

826.8x

Earnings Reports

Q1 2026

May 5, 2026

PENDING

FY 2025

Feb 26, 2026

$1.2B+6.5%EPS $0.04

Q4 2025

Feb 26, 2026

$314M+2.3%EPS -$0.05

Q3 2025

Nov 5, 2025

$311M+10.0%EPS $0.12

Q2 2025

Aug 6, 2025

$291M+5.0%EPS $0.12

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$319M	$150M	$5M
Q2 22	$331M	$158M	$12M
Q3 22	$348M	$159M	$18M
Q4 22	$298M	$122M	-$38M
Q1 23	$291M	$125M	-$23M
Q2 23	$299M	$134M	$8M
Q3 23	$299M	$132M	$4M
Q4 23	$259M	$105M	-$23M
Q1 24	$246M	$95M	-$19M
Q2 24	$277M	$114M	$3M
Q3 24	$282M	$123M	$7M
Q4 24	$307M	$143M	$14M
Q1 25	$270M	$111M	-$12M
Q2 25	$291M	$128M	$8M
Q3 25	$311M	$135M	$8M
Q4 25	$314M	$130M	$415.0K

Valuation

Quarter	P/S	P/E
Q1 22	5.2x	86.8x
Q2 22	4.4x	90.6x
Q3 22	3.1x	83.7x
Q4 22	1.9x	427.9x
Q1 23	2.1x	—
Q2 23	2.7x	—
Q3 23	1.7x	—
Q4 23	1.4x	—
Q1 24	1.2x	—
Q2 24	1.1x	—
Q3 24	1.9x	—
Q4 24	1.8x	159.6x
Q1 25	1.4x	76.5x
Q2 25	1.2x	59.3x
Q3 25	1.2x	71.1x
Q4 25	1.8x	1041.2x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$16M	-$31M
Q2 22	-$10M	-$19M
Q3 22	$21M	$8M
Q4 22	$82M	$68M
Q1 23	$13M	$3M
Q2 23	$73M	$61M
Q3 23	$57M	$46M
Q4 23	$38M	$26M
Q1 24	$50M	$38M
Q2 24	$59M	$45M
Q3 24	$23M	$9M
Q4 24	$56M	$47M
Q1 25	$26M	$15M
Q2 25	$43M	$31M
Q3 25	$28M	$19M
Q4 25	$30M	$20M

Capital Expenditures

Quarter	CapEx
Q1 22	$15M
Q2 22	$10M
Q3 22	$13M
Q4 22	$14M
Q1 23	$10M
Q2 23	$12M
Q3 23	$11M
Q4 23	$12M
Q1 24	$12M
Q2 24	$14M
Q3 24	$13M
Q4 24	$9M
Q1 25	$11M
Q2 25	$12M
Q3 25	$10M
Q4 25	$10M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+26.6%	+35.1%
Q2 22	+21.5%	+30.8%
Q3 22	+17.4%	+23.4%
Q4 22	-4.3%	+12.2%
Q1 23	-8.8%	-0.0%
Q2 23	-9.8%	-8.7%
Q3 23	-14.2%	-10.5%
Q4 23	-13.0%	-16.0%
Q1 24	-15.3%	-15.5%
Q2 24	-7.4%	-6.1%
Q3 24	-5.4%	-6.7%
Q4 24	+18.6%	+3.9%
Q1 25	+9.6%	+6.2%
Q2 25	+5.0%	+3.2%
Q3 25	+10.0%	+9.9%
Q4 25	+2.3%	+7.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$16M	5.1%
Q2 22	$17M	5.2%
Q3 22	$17M	5.0%
Q4 22	$18M	5.9%
Q1 23	$14M	4.8%
Q2 23	$14M	4.7%
Q3 23	$15M	5.0%
Q4 23	$12M	4.7%
Q1 24	$9M	3.5%
Q2 24	$10M	3.6%
Q3 24	$12M	4.1%
Q4 24	$9M	2.9%
Q1 25	$11M	4.0%
Q2 25	$11M	3.6%
Q3 25	$11M	3.6%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 22	$25M	—	$120M
Q2 22	$26M	$119M	—
Q3 22	$25M	—	$115M
Q4 22	$28M	—	$132M
Q1 23	$23M	—	$125M
Q2 23	$23M	$104M	—
Q3 23	$24M	—	$104M
Q4 23	$27M	$104M	—
Q1 24	$22M	—	$92M
Q2 24	$21M	—	$90M
Q3 24	$21M	—	$94M
Q4 24	$26M	—	$103M
Q1 25	$21M	—	$102M
Q2 25	$22M	—	$98M
Q3 25	$24M	—	$102M
Q4 25	$23M	—	$107M

Revenue Segments

Quarter	Connected Devices, Software Licenses, And Other	Consumables	Hardware And Software	Technical Services	Advanced Services
Q1 22	$208M	$18M	$44M	$49M	—
Q2 22	$216M	$18M	$44M	$53M	—
Q3 22	$226M	$20M	$48M	$54M	—
Q4 22	$178M	$19M	$50M	$50M	—
Q1 23	$165M	$21M	—	$53M	$52M
Q2 23	$167M	$21M	—	$57M	$53M
Q3 23	$168M	$21M	—	$57M	$53M
Q4 23	$123M	$22M	—	$58M	$55M
Q1 24	$111M	$22M	—	$59M	$54M
Q2 24	$135M	$22M	—	$59M	$61M
Q3 24	$136M	$23M	—	$60M	$64M
Q4 24	$158M	$24M	—	$61M	$64M
Q1 25	$120M	$25M	$63M	$61M	—
Q2 25	$139M	$25M	$64M	$64M	—
Q3 25	$153M	$25M	$66M	$67M	—
Q4 25	$154M	$26M	$66M	$68M	—

Revenue by Geography

Quarter	Non-US	United States
Q1 22	$31M	$288M
Q2 22	$36M	$295M
Q3 22	$32M	$316M
Q4 22	$28M	$270M
Q1 23	$35M	$256M
Q2 23	$42M	$257M
Q3 23	$26M	$273M
Q4 23	$33M	$226M
Q1 24	$28M	$218M
Q2 24	$21M	$255M
Q3 24	$24M	$258M
Q4 24	$26M	$281M
Q1 25	$20M	$249M
Q2 25	$27M	$263M
Q3 25	$32M	$278M
Q4 25	$40M	$274M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$265M	$11M	$276M
Q2 22	$245M	$12M	$257M
Q3 22	$266M	$13M	$279M
Q4 22	$330M	$11M	$342M
Q1 23	$340M	$11M	$351M
Q2 23	$399M	$11M	$411M
Q3 23	$447M	$12M	$458M
Q4 23	$468M	$0	$468M
Q1 24	$512M	$12M	$524M
Q2 24	$557M	$13M	$569M
Q3 24	$571M	$12M	$582M
Q4 24	$369M	$12M	$382M
Q1 25	$387M	$13M	$399M
Q2 25	$399M	$13M	$412M
Q3 25	$180M	$13M	$193M
Q4 25	$197M	$0	$197M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	48M	-3.9%	+3.3%
Q2 22	46M	-3.5%	-1.8%
Q3 22	46M	-1.0%	-5.2%
Q4 22	45M	-2.5%	-10.4%
Q1 23	45M	+0.5%	-6.3%
Q2 23	45M	+1.3%	-1.7%
Q3 23	46M	+0.3%	-0.5%
Q4 23	45M	-0.2%	+1.8%
Q1 24	46M	+0.5%	+1.9%
Q2 24	46M	+0.7%	+1.2%
Q3 24	46M	+0.8%	+1.8%
Q4 24	46M	-0.4%	+1.7%
Q1 25	47M	+0.7%	+1.9%
Q2 25	47M	+0.2%	+1.4%
Q3 25	47M	-0.1%	+0.5%
Q4 25	45M	-3.6%	-2.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$83.9K	4K
Q2 22	$87.2K	4K
Q3 22	$91.6K	4K
Q4 22	$70.4K	4K
Q1 23	$68.7K	4K
Q2 23	$70.7K	4K
Q3 23	$70.6K	4K
Q4 23	$70.9K	4K
Q1 24	$67.4K	4K
Q2 24	$75.8K	4K
Q3 24	$77.4K	4K
Q4 24	$83.6K	4K
Q1 25	$73.5K	4K
Q2 25	$79.2K	4K
Q3 25	$84.6K	4K
Q4 25	$87.7K	4K

Revenue / Employee